Concepedia

Tomoyuki Hayamizu

TH

Statistics

Publications

6

Citations

90

H-Index

6

Active since

2015

Affiliations

GlaxoSmithKline (Japan)(Current)

GlaxoSmithKline (United Kingdom)

Keio University

Pfizer (Japan)

Tomoyuki Hayamizu is an author at GlaxoSmithKline (Japan) specializing in chronic obstructive pulmonary disease, pulmonary function assessment, and pulmonology.

ORCID

Publications per year

2015–2024

6

Publications

6

Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls

Tomoyuki Hayamizu, Nobuhisa Ishikawa, Noboru Hattori et al. · International Journal of COPD · 2015 · 22 citations · Full text

, , +17

Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine for routine pediatric vaccination programs in Japan

Masayoshi Shinjoh, Kanae Togo, Tomoyuki Hayamizu et al. · Expert Review of Vaccines · 2024 · 16 citations · Full text

, , +17

Responsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls

Tomoyuki Hayamizu, Tomotaka Kawayama, Takashi Kinoshita et al. · International Journal of COPD · 2016 · 14 citations · Full text

, , +16

A randomized trial of symptom-based management in Japanese patients with COPD

Tomoko Betsuyaku, Motokazu Kato, Keisaku Fujimoto et al. · International Journal of COPD · 2018 · 13 citations · Full text

, , +17

Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan

Shigeki Nakamura, Masashi Mikami, Tomoyuki Hayamizu et al. · Expert Review of Vaccines · 2024 · 13 citations · Full text

, , +17

1–5 of 6